contact dermatitis

(redirected from contact hypersensitivity)
Also found in: Thesaurus, Medical, Legal, Encyclopedia.

contact dermatitis

n.
An acute or chronic skin inflammation resulting from contact with an irritating substance or allergen.

contact dermatitis

Inflammation of the skin due to irritants or allergic reaction. Irritants can be chemicals, metals, certain plants, or drugs. Symptoms can vary in severity from itching to cracks and bleeding.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.contact dermatitis - a delayed type of allergic reaction of the skin resulting from skin contact with a specific allergen (such as poison ivy)
bubble gum dermatitis - an allergic contact dermatitis developed around the lips of children who chew bubble gum
Rhus dermatitis - contact dermatitis resulting from contact with plants of the genus Toxicodendron
dermatitis - inflammation of the skin; skin becomes itchy and may develop blisters
References in periodicals archive ?
Additionally, topical application of 1-3 ppm avenanthramides mitigated inflammation in murine models of contact hypersensitivity and neurogenic inflammation and reduced pruritogen-induced scratching in a murine itch model.
Researchers induced contact hypersensitivity reaction with oxazolone, a chemical allergen used for immunological experiments and found that bortezomib significantly inhibited the contact hypersensitivity responses.
Five earlier safety studies involving a total of 667 patients showed no phototoxicity, contact hypersensitivity, irritation, photoallergic response, or sensitization.
For example, astilbin alleviated contact hypersensitivity by inhibiting Th1 cytokine production and stimulating endogenous interleukin-10, and it upregulated the downstream proteins of interleukin-10, suppressor of cytokine signaling 1 (SOCS1), and SOCS3.
The results of the first study conducted on hairless guinea pigs concluded that there was no evidence of primary irritancy, photo toxicity, contact hypersensitivity or photoallergy in response to topical administration of the placebo or the QR-333 cream at a dose volume as high as 0.
1% undecyl dimethyl oxazoline, are able to delay the development of cutaneous contact hypersensitivity (CHS), according to Nathalie Piccardi, Laboratories Expanscience.